Muscle biopsy findings in inflammatory myopathies
- PMID: 12506772
- DOI: 10.1016/s0889-857x(02)00030-3
Muscle biopsy findings in inflammatory myopathies
Abstract
The inflammatory myopathies encompass a heterogeneous group of acquired muscle diseases characterized clinically, by muscle weakness, and histologically, by inflammatory infiltrates within the skeletal muscles. The group of these myopathies comprise three major and discrete subsets: polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM). Each subset retains its characteristic clinical, immunopathologic, and morphologic features regardless of whether it occurs separately or in connection with other systemic diseases. Although the diagnosis of these disorders is based on the combination of clinical examination, electromyographic data, serum muscle enzyme levels, various autoantibodies, and the muscle biopsy findings, the muscle biopsy offers the most definitive diagnostic information in the majority of the cases. This article summarizes the main histologic features that characterize PM, DM, or IBM and emphasizes the main pitfalls associated with interpretation of the biopsies.
Similar articles
-
[Inflammatory myopathies: diagnosis and classifications].Presse Med. 2009 Jul-Aug;38(7-8):1141-63. doi: 10.1016/j.lpm.2009.01.013. Epub 2009 Mar 17. Presse Med. 2009. PMID: 19282137 Review. French.
-
Update on idiopathic inflammatory myopathies.Autoimmunity. 2006 May;39(3):161-70. doi: 10.1080/08916930600622132. Autoimmunity. 2006. PMID: 16769649 Review.
-
[Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].Presse Med. 2003 Oct 25;32(35):1656-67. Presse Med. 2003. PMID: 14631270 Review. French.
-
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.Arthritis Rheum. 1997 May;40(5):865-74. doi: 10.1002/art.1780400514. Arthritis Rheum. 1997. PMID: 9153548
-
A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.Ann N Y Acad Sci. 2009 Sep;1173:463-9. doi: 10.1111/j.1749-6632.2009.04812.x. Ann N Y Acad Sci. 2009. PMID: 19758187
Cited by
-
CYLD dysregulation in pathogenesis of sporadic inclusion body myositis.Sci Rep. 2019 Aug 12;9(1):11606. doi: 10.1038/s41598-019-48115-2. Sci Rep. 2019. PMID: 31406156 Free PMC article.
-
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype.Arthritis Res Ther. 2006;8(1):R13. doi: 10.1186/ar1862. Arthritis Res Ther. 2006. PMID: 16507114 Free PMC article.
-
Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.Arthritis Res Ther. 2014 Jan 27;16(1):R26. doi: 10.1186/ar4454. Arthritis Res Ther. 2014. PMID: 24467773 Free PMC article.
-
Multi-parametric MRI characterization of inflammation in murine skeletal muscle.NMR Biomed. 2014 Jun;27(6):716-25. doi: 10.1002/nbm.3113. Epub 2014 Apr 29. NMR Biomed. 2014. PMID: 24777935 Free PMC article.
-
Interleukin-37 (IL-37) Suppresses Pertussis Toxin-Induced Inflammatory Myopathy in a Rat Model.Med Sci Monit. 2018 Dec 18;24:9187-9195. doi: 10.12659/MSM.910904. Med Sci Monit. 2018. PMID: 30559337 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical